Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs.
Davì
G
G
Pinto
A
A
Francavilla
G
G
Paterna
S
S
Campisi
D
D
Strano
A
A
D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000097:blood / Q000188:drug therapy*; D001792:Blood Platelets / Q000187:drug effects*; D004311:Double-Blind Method; D004357:Drug Synergism; D011464:Epoprostenol / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D010978:Platelet Factor 4 / Q000032:analysis; D013876:Thiophenes / Q000627:therapeutic use*; D013929:Thromboxane B2 / Q000032:analysis; D013988:Ticlopidine; D001620:beta-Thromboglobulin / Q000032:analysis
D013876:Thiophenes; D001620:beta-Thromboglobulin; D010978:Platelet Factor 4; D013929:Thromboxane B2; D011464:Epoprostenol; D013988:Ticlopidine